Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 107 citing Hanley: Elevations in markers of liver injury and risk of type 2 diabetes. (0.08 sec) 

Fat in the liver and insulin resistance


H Yki-Järvinen - Annals of Medicine, 2005 - informahealthcare.com
Insulin resistance in humans is not always accompanied by obesity, since severe insulin resistance
also characterizes patients lacking subcutaneous fat such as those with HAART‐ (highly‐active
antiretroviral therapy)‐associated lipodystrophy. Both obese and lipodystrophic patients, ...
Cited by 145 - Related articles - BL Direct - All 10 versions

Nonalcoholic fatty liver disease and risk of future cardiovascular events among …

- diabetesjournals.org
G Targher, L Bertolini, F Poli, S Rodella, L Scala, R … - Diabetes, 2005 - Am Diabetes Assoc
Nonalcoholic fatty liver disease (NAFLD) is closely correlated to several metabolic syndrome
features. We assessed prospectively whether NAFLD predicts future cardiovascular disease
(CVD) events among type 2 diabetic individuals, independent of metabolic syndrome ...
Cited by 114 - Related articles - BL Direct - All 5 versions

Liver markers and development of the metabolic syndrome

- diabetesjournals.org
AJG Hanley, K Williams, A Festa, LE Wagenknecht, RB … - Diabetes, 2005 - Am Diabetes Assoc
Nonalcoholic fatty liver disease (NAFLD) is emerging as a component of the metabolic
syndrome, although it is not known whether markers of NAFLD, including elevated concentrations
of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline ...
Cited by 117 - Related articles - BL Direct - All 6 versions

Overproduction of large VLDL particles is driven by increased liver fat content in …


M Adiels, MR Taskinen, C Packard, MJ Caslake, A … - Diabetologia, 2006 - Springer
Page 1. Diabetologia (2006) 49: 755–765 DOI 10.1007/s00125-005-0125-z ARTICLE M.
Adiels . M.-R. Taskinen . C. Packard . MJ Caslake . A. Soro-Paavonen . J. Westerbacka . S.
Vehkavaara . A. Häkkinen . S.-O. Olofsson . H. Yki-Järvinen . J. Borén ...
Cited by 116 - Related articles - BL Direct - All 5 versions

Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City …


M Nannipieri, C Gonzales, S Baldi, R Posadas, K … - Diabetes Care, 2005 - 万方数据资源系统
OBJECTIVE: To test the hypothesis that enzymes conventionally associated with liver dysfunction
(aspartate aminotransferase, alanine aminotransferase, gamma-glutamyltransferase [GGT], and
alkaline phosphatase) may predict diabetes. RESEARCH DESIGN AND METHODS ...
Cited by 101 - Related articles - BL Direct - All 4 versions

Relation between elevated serum alanine aminotransferase and metabolic …

- cnfindpark.cn
HS Park, JH Han, KM Choi, SM Kim - American Journal of Clinical …, 2005 - ajcn.cnfindpark.cn
Results: The prevalence of elevated ALT (>40 U/L) was 3.6% in boys and 2.8% in girls. The prevalence
of metabolic syndrome was 3.3% in both boys and girls. The components of the metabolic syndrome
were significantly worse in the group with elevated ALT concentrations than in the group ...
Cited by 65 - Related articles - BL Direct - All 12 versions

Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in …


RK Schindhelm, M Diamant, JM Dekker, ME … - Diabetes/Metabolism … - interscience.wiley.com
For a long time, hepatic steatosis was believed to be a benign condition. Only recently, liver
steatosis, also termed non-alcoholic fatty liver disease (NAFLD), has gained much interest. In
most cases of NAFLD, a condition regarded as the hepatic component of the metabolic ...
Cited by 63 - Related articles - BL Direct - All 3 versions

Relationship of metabolic risk factors and development of cardiovascular disease …


SM Haffner - Obesity, 2006 - nature.com
The prevalence of obesity and diabetes has reached pandemic proportions. Obesity, particularly
in association with high waist circumference and high BMI, is an independent risk factor for coronary
heart disease (CHD) and diabetes. Several large studies have shown that marginal (5 lb) ...
Cited by 51 - Related articles - All 5 versions

Abdominal adiposity and cardiometabolic risk: do we have all the answers?


SM Haffner - The American Journal of Medicine, 2007 - Elsevier
Overweight and obesity, particularly abdominal adiposity, increase the risk for type 2 diabetes
mellitus and cardiovascular disease (CVD). Metabolic syndrome, a constellation of risk factors
that includes elevated triglycerides, low high-density lipoprotein cholesterol, elevated ...
Cited by 36 - Related articles - All 7 versions

Serial metabolic measurements and conversion to type 2 diabetes in the West of …


N Sattar, A McConnachie, I Ford, A Gaw, SJ Cleland, … - Diabetes, 2007 - Am Diabetes Assoc
To examine metabolic changes (lipids, liver enzymes, blood pressure, and weight) potentially
associated with conversion to diabetes, we analyzed serial glucose and other metabolic measures
obtained every 6 months within the West of Scotland Coronary Prevention Study trial. ...
Cited by 30 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google